{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:31:05Z","timestamp":1787063465438,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01MH106781"],"award-info":[{"award-number":["R01MH106781"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K01DK087813"],"award-info":[{"award-number":["K01DK087813"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH West Coast Metabolomics Center Pilot Award","award":["(U24DK097154)"],"award-info":[{"award-number":["(U24DK097154)"]}]},{"name":"Price Foundation of Switzerland and NARSAD Young Investigator Grant","award":["R01MH092793"],"award-info":[{"award-number":["R01MH092793"]}]},{"name":"Price Foundation of Switzerland and NARSAD Young Investigator Grant","award":["R01ES002710"],"award-info":[{"award-number":["R01ES002710"]}]},{"name":"Price Foundation of Switzerland and NARSAD Young Investigator Grant","award":["P42ES004699"],"award-info":[{"award-number":["P42ES004699"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.prostaglandins.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T05:32:23Z","timestamp":1487655143000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa"],"prefix":"10.1016","volume":"132","author":[{"given":"Pei-an Betty","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.prostaglandins.2017.02.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002646","article-title":"The incidence of eating disorders in the UK in 2000\u20132009: findings from the General Practice Research Database","volume":"3","author":"Micali","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.prostaglandins.2017.02.002_bib0010","series-title":"American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.02.002_bib0015","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archgenpsychiatry.2011.74","article-title":"Mortality rates in patients with anorexia nervosa and other eating disorders: a meta-analysis of 36 studies","volume":"68","author":"Arcelus","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.02.002_bib0020","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1176\/appi.ajp.159.8.1284","article-title":"The outcome of anorexia nervosa in the 20th century","volume":"159","author":"Steinhausen","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.02.002_bib0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1176\/appi.ajp.157.3.393","article-title":"Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes","volume":"157","author":"Strober","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.02.002_bib0030","first-page":"262","article-title":"Heritability, genetics and association findings in anorexia nervosa","volume":"39","author":"Ben-Dor","year":"2002","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.02.002_bib0035","first-page":"254","article-title":"Toward the understanding of anorexia nervosa as a disease entity","volume":"56","author":"Lucas","year":"1981","journal-title":"Mayo Clin. Proc."},{"issue":"9101","key":"10.1016\/j.prostaglandins.2017.02.002_bib0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(05)78688-8","article-title":"Lack of association between 5-HT2A gene promoter polymorphism and susceptibility to anorexia nervosa","volume":"351","author":"Campbell","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.02.002_bib0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.euroneuro.2016.02.008","article-title":"Contemporary views on the genetics of anorexia nervosa","volume":"26","author":"Shih","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.02.002_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.mp.4001318","article-title":"Candidate genes for anorexia nervosa in the 1 p 33\u201336 linkage region: serotonin 1 D and delta opioid receptor loci exhibit significant association to anorexia nervosa","volume":"8","author":"Bergen","year":"2003","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.02.002_bib0055","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/sj.npp.1300719","article-title":"Association of multiple DRD2 polymorphisms with anorexia nervosa","volume":"30","author":"Bergen","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.02.002_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1568007033338760","article-title":"Candidate gene analysis of the Price Foundation anorexia nervosa affected relative pair dataset","volume":"2","author":"Bergen","year":"2003","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.02.002_bib0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/ajmg.b.31082","article-title":"Association study of 182 candidate genes in anorexia nervosa","volume":"153 B","author":"Pinheiro","year":"2010","journal-title":"Am. J. Med. Genet. Part B"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.02.002_bib0070","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/mp.2013.91","article-title":"Evidence for the role of EPHX2 gene variants in anorexia nervosa","volume":"19","author":"Scott-Van Zeeland","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.02.002_bib0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ajmg.b.30226","article-title":"Linkage analysis of anorexia and bulimia nervosa cohorts using selected behavioral phenotypes as quantitative traits or covariates","volume":"139 B","author":"Bacanu","year":"2005","journal-title":"Am. J. Med. Genet. Part B"},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.02.002_bib0080","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/mp.2013.187","article-title":"A genome-wide association study of anorexia nervosa","volume":"19","author":"Boraska","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.02.002_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajmg.b.30227","article-title":"Selection of eating-disorder phenotypes for linkage analysis","volume":"139 B","author":"Bulik","year":"2005","journal-title":"Am. J. Med. Genet. Part B"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.02.002_bib0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/hmg\/11.6.689","article-title":"Linkage analysis of anorexia nervosa incorporating behavioral covariates","volume":"11","author":"Devlin","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.02.002_bib0095","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/339250","article-title":"Evidence for a susceptibility gene for anorexia nervosa on chromosome 1","volume":"70","author":"Grice","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.02.002_bib0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/jhg.2009.74","article-title":"Identification of novel candidate loci for anorexia nervosa at 1 q41 and 11 q22 in Japanese by a genome-wide association analysis with microsatellite markers","volume":"54","author":"Nakabayashi","year":"2009","journal-title":"J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.02.002_bib0105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/mp.2010.107","article-title":"A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa","volume":"16","author":"Wang","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.02.002_bib0110","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/hmg\/ddl085","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"15","author":"Lee","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.02.002_bib0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3132\/dvdr.2008.021","article-title":"Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study","volume":"5","author":"Burdon","year":"2008","journal-title":"Diabetes Vasc. Dis. Res.: Off. J. Int. Soc. Diabetes Vasc. Dis."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.02.002_bib0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FPC.0b013e3283349ec9","article-title":"Homozygosity for the EPHX2 K55 R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes","volume":"20","author":"Fava","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.prostaglandins.2017.02.002_bib0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.prostaglandins.2014.08.001","article-title":"Arg287 Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans","volume":"113\u2013115","author":"Ramirez","year":"2014","journal-title":"Prostag. Other Lipid Mediators"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.02.002_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10038-003-0103-6","article-title":"Soluble epoxide hydrolase variant (Glu287 Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred","volume":"49","author":"Sato","year":"2004","journal-title":"J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.02.002_bib0135","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.transproceed.2008.03.137","article-title":"Genetic variations in soluble epoxide hydrolase and graft function in kidney transplantation","volume":"40","author":"Lee","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.prostaglandins.2017.02.002_bib0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.pharmtox.45.120403.095920","article-title":"Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles","volume":"45","author":"Morisseau","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.02.002_bib0145","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/pr.113.007781","article-title":"The pharmacology of the cytochrome P450 epoxygenase\/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease","volume":"66","author":"Fleming","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.02.002_bib0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.intimp.2004.10.005","article-title":"COX expression and PGE(2) and PGD(2) production in experimental acute and chronic gastric lesions","volume":"5","author":"Motilva","year":"2005","journal-title":"Int. Immunopharmacol."},{"issue":"5548","key":"10.1016\/j.prostaglandins.2017.02.002_bib0155","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"28","key":"10.1016\/j.prostaglandins.2017.02.002_bib0160","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.0503279102","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","volume":"102","author":"Schmelzer","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.02.002_bib0165","doi-asserted-by":"crossref","first-page":"e39165","DOI":"10.1371\/journal.pone.0039165","article-title":"Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.02.002_bib0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/pmt.11.47","article-title":"The soluble epoxide hydrolase as a pharmaceutical target for pain management","volume":"1","author":"Hammock","year":"2011","journal-title":"Pain Manage."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.02.002_bib0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0195-6663(88)90063-3","article-title":"Fat aversion in eating disorders","volume":"10","author":"Drewnowski","year":"1988","journal-title":"Appetite"},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.02.002_bib0180","first-page":"671","article-title":"Food preferences and aversions and dietary pattern in anorexia nervosa patients","volume":"42","author":"Van Binsbergen","year":"1988","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.02.002_bib0185","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.appet.2010.05.090","article-title":"Pre-meal anxiety and food intake in anorexia nervosa","volume":"55","author":"Steinglass","year":"2010","journal-title":"Appetite"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.02.002_bib0190","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2015.26","article-title":"Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa","volume":"21","author":"Shih","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.prostaglandins.2017.02.002_bib0195","series-title":"Paper Presented at the Hot Topics Session","article-title":"Application of sequencing, fatty acid profiling, and metabolomics investigations to explore pathogenesis and treatment strategy for anorexia nervosa","author":"Shih","year":"2013"},{"key":"10.1016\/j.prostaglandins.2017.02.002_bib0200","first-page":"S323","article-title":"A pilot study of soluble epoxide hydrolase activity in eating disorders","volume":"9","author":"Shih","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"2015","key":"10.1016\/j.prostaglandins.2017.02.002_bib0205","first-page":"S302","article-title":"Substrate-dependent postprandial oxylipin responses reveal the potential role of nutrient-gene interaction in anorexia nervosa","volume":"40","author":"Yang","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.02.002_bib0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/eat.20509","article-title":"The genetics of anorexia nervosa collaborative study: methods and sample description","volume":"41","author":"Kaye","year":"2008","journal-title":"Int. J. Eat. Disord."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.02.002_bib0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pscychresns.2015.10.010","article-title":"Altered sensitization patterns to sweet food stimuli in patients recovered from anorexia and bulimia nervosa","volume":"234","author":"Wagner","year":"2015","journal-title":"Psychiatry Res."},{"issue":"4.23","key":"10.1016\/j.prostaglandins.2017.02.002_bib0220","first-page":"1","article-title":"Measurements of soluble epoxide hydrolase (sEH) activity","volume":"33","author":"Morisseau","year":"2007","journal-title":"Curr. Protoc. Toxicol"},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.02.002_bib0225","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbalip.2011.07.006","article-title":"High sensitivity quantitative lipidomics analysis of fatty acids in biological samples by gas chromatography-mass spectrometry","volume":"1811","author":"Quehenberger","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.02.002_bib0230","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s11306-012-0417-5","article-title":"Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations","volume":"8","author":"Zivkovic","year":"2012","journal-title":"Metabol.: Off. J. Metabol. Soc."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.02.002_bib0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/MOL.0b013e3283468c10","article-title":"Profiling the regulatory lipids: another systemic way to unveil the biological mystery","volume":"22","author":"Yang","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"issue":"19","key":"10.1016\/j.prostaglandins.2017.02.002_bib0240","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1021\/ac901282n","article-title":"Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry","volume":"81","author":"Yang","year":"2009","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.02.002_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2004.10.001","article-title":"Epoxide hydrolases: their roles and interactions with lipid metabolism","volume":"44","author":"Newman","year":"2005","journal-title":"Prog. Lipid Res."},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.02.002_bib0250","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/npp.2011.108","article-title":"Genetic association of recovery from eating disorders: the role of GABA receptor SNPs","volume":"36","author":"Bloss","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.02.002_bib0255","doi-asserted-by":"crossref","first-page":"F1283","DOI":"10.1152\/ajprenal.00733.2010","article-title":"In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy","volume":"300","author":"Lee","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.02.002_bib0260","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1124\/jpet.108.142398","article-title":"Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation","volume":"327","author":"Fife","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.02.002_bib0265","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/eat.22133","article-title":"Genetic variants associated with disordered eating","volume":"46","author":"Wade","year":"2013","journal-title":"Int. J. Eat. Disord."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.02.002_bib0270","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0006-3223(99)00240-1","article-title":"A search for susceptibility loci for anorexia nervosa: methods and sample description","volume":"47","author":"Kaye","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.02.002_bib0275","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/nu4091338","article-title":"Consequences of essential fatty acids","volume":"4","author":"Lands","year":"2012","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.02.002_bib0280","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","article-title":"Thematic Review Series: proteomics. An integrated omics analysis of eicosanoid biology","volume":"50","author":"Buczynski","year":"2009","journal-title":"J. Lipid Res."},{"issue":"43","key":"10.1016\/j.prostaglandins.2017.02.002_bib0285","doi-asserted-by":"crossref","first-page":"32720","DOI":"10.1074\/jbc.M110.118406","article-title":"Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids","volume":"285","author":"Arnold","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.02.002_bib0290","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1517\/17425255.2015.1052791","article-title":"Effect of Cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors","volume":"11","author":"Probst-Schendzielorz","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.02.002_bib0295","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/mp.2013.89","article-title":"Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2 C19 gene","volume":"19","author":"Persson","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.02.002_bib0300","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/mp.2011.5","article-title":"High risk of lifetime history of suicide attempts among CYP2 D6 ultrarapid metabolizers with eating disorders","volume":"16","author":"Penas-Lledo","year":"2011","journal-title":"Mol. Psychiatry"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T11:54:20Z","timestamp":1719057260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317300230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":60,"alternative-id":["S1098882317300230"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.02.002","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}